Your browser doesn't support javascript.
loading
Generation of glioblastoma in mice engrafted with human cytomegalovirus-infected astrocytes.
Guyon, Joris; Haidar Ahmad, Sandy; El Baba, Ranim; Le Quang, Mégane; Bikfalvi, Andreas; Daubon, Thomas; Herbein, Georges.
Afiliación
  • Guyon J; University of Bordeaux, INSERM U1312, BRIC, Bordeaux, France.
  • Haidar Ahmad S; CHU Bordeaux, Department of Medical Pharmacology, Bordeaux, France.
  • El Baba R; University of Franche-Comté, Pathogens & Inflammation/EPILAB Laboratory, EA 4266, Besançon, France.
  • Le Quang M; University of Franche-Comté, Pathogens & Inflammation/EPILAB Laboratory, EA 4266, Besançon, France.
  • Bikfalvi A; Pathology Department, University Hospital of Bordeaux, Bordeaux, France.
  • Daubon T; University of Bordeaux, INSERM U1312, BRIC, Bordeaux, France.
  • Herbein G; University of Bordeaux, CNRS, IBGC UMR5095, Bordeaux, France.
Cancer Gene Ther ; 31(7): 1070-1080, 2024 Jul.
Article en En | MEDLINE | ID: mdl-38553638
ABSTRACT
Mounting evidence is identifying human cytomegalovirus (HCMV) as a potential oncogenic virus. HCMV has been detected in glioblastoma multiforme (GB). Herewith, we present the first experimental evidence for the generation of CMV-Elicited Glioblastoma Cells (CEGBCs) possessing glioblastoma-like traits that lead to the formation of glioblastoma in orthotopically xenografted mice. In addition to the already reported oncogenic HCMV-DB strain, we isolated three HCMV clinical strains from GB tissues that transformed HAs toward CEGBCs and generated spheroids from CEGBCs that resulted in the appearance of glioblastoma-like tumors in xenografted mice. These tumors were nestin-positive mostly in the invasive part surrounded by GFAP-positive reactive astrocytes. The glioblastoma immunohistochemistry phenotype was confirmed by EGFR and cMet gene amplification in the tumor parallel to the detection of HCMV IE and UL69 genes and proteins. Our results fit with an HCMV-induced glioblastoma model of oncogenesis in vivo which will open the door to new therapeutic approaches and assess the anti-HCMV treatment as well as immunotherapy in fighting GB which is characterized by poor prognosis.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Astrocitos / Glioblastoma / Citomegalovirus Límite: Animals / Humans Idioma: En Revista: Cancer Gene Ther Asunto de la revista: GENETICA MEDICA / NEOPLASIAS / TERAPEUTICA Año: 2024 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Astrocitos / Glioblastoma / Citomegalovirus Límite: Animals / Humans Idioma: En Revista: Cancer Gene Ther Asunto de la revista: GENETICA MEDICA / NEOPLASIAS / TERAPEUTICA Año: 2024 Tipo del documento: Article País de afiliación: Francia